2015
DOI: 10.1016/j.clinbiochem.2015.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(19 citation statements)
references
References 35 publications
1
18
0
Order By: Relevance
“…PenaSanchez et al compared the activities of AOPP in 25 patients suffering from Alzheimer's disease and 30 healthy controls. They observed a significant difference in AOPP levels between control and patient groups (49). Recent investigations on the levels of AOPP in plasma and spinal liquid in amyotrophic sclerosis patients indicated the association of AOPP level with premature sclerosis and nervous tissue damages (50).…”
Section: Discussionmentioning
confidence: 99%
“…PenaSanchez et al compared the activities of AOPP in 25 patients suffering from Alzheimer's disease and 30 healthy controls. They observed a significant difference in AOPP levels between control and patient groups (49). Recent investigations on the levels of AOPP in plasma and spinal liquid in amyotrophic sclerosis patients indicated the association of AOPP level with premature sclerosis and nervous tissue damages (50).…”
Section: Discussionmentioning
confidence: 99%
“…Huntington’s disease (HD) is a genetic, autosomal dominant disorder characterized by general neurodegeneration in brain with marked deterioration of medium-sized spiny neurons (MSNs) in the striatum [ 17 , 113 ]. HD is caused by a mutation (a CAG expansion) in the huntingtin gene ( HTT ), which results in an abnormal polyglutamine expansion in the huntingtin (HTT) protein and consequently HTT aggregation [ 113 ]. The mutant HTT alters intracellular Ca 2+ homeostasis, induces mitochondrial dysfunction, disrupts intracellular trafficking and impairs gene transcription [ 114 ].…”
Section: Role Of Vitamin C In Neurodegenerative Diseasesmentioning
confidence: 99%
“…Oxidative damages in basal ganglia are found even in other degenerative disorders such multiple system atrophy, progressive supranuclear palsy and Huntington's disease [18][19][20]. Moreover, studies on biochemical changes occurring in Alzheimer's disease (AD), motor neuron disease and diabetic neuropathy also suggest the involvement of free radicals in neurodegeneration process [21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%